Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

New vasopressin V1a/V2 modulators for renal failure and hypertension

Aug. 7, 2002

AVI-4126 completes phase Ib polycystic kidney disease trial

Aug. 7, 2002

Swedish approval for dutasteride for benign prostatic hyperplasia

July 30, 2002

CPMP hands down positive opinion for Cialis

July 29, 2002

Approvable letter received for vardenafil

July 25, 2002

Vasopressin antagonists identified at Yamanouchi

July 25, 2002

Renal cytoprotective effects demonstrated for calpain inhibitors

July 25, 2002

Uroselective alpha1A-adrenoceptor antagonists and their use in BPH described by Ranbaxy

July 24, 2002

Altair develops new drug for hyperphosphatemia in hemodialysis patients

July 23, 2002

Elitek approved in U.S.

July 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.